Analysis of protein kinases by quantitative chemical proteomics

2007 ◽  
Vol 2007 (Fall) ◽  
Author(s):  
Henrik Daub ◽  
Jesper V. Olsen ◽  
Michaela Bairlein ◽  
Florian Gnad ◽  
Felix Oppermann ◽  
...  
2021 ◽  
Vol 2 (2) ◽  
pp. 100593
Author(s):  
Wankyu Lee ◽  
Zhen Huang ◽  
Christopher W. am Ende ◽  
Uthpala Seneviratne

2018 ◽  
Vol 58 (2) ◽  
pp. 537-541 ◽  
Author(s):  
Yunan Li ◽  
Jonathan Evers ◽  
Ang Luo ◽  
Luke Erber ◽  
Zachary Postler ◽  
...  

2011 ◽  
Vol 10 (12) ◽  
pp. M111.011635 ◽  
Author(s):  
Zhixiang Wu ◽  
Jessica B. Doondeea ◽  
Amin Moghaddas Gholami ◽  
Melanie C. Janning ◽  
Simone Lemeer ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
H. Christian Eberl ◽  
Thilo Werner ◽  
Friedrich B. Reinhard ◽  
Stephanie Lehmann ◽  
Douglas Thomson ◽  
...  

Abstract Kinobeads are a set of promiscuous kinase inhibitors immobilized on sepharose beads for the comprehensive enrichment of endogenously expressed protein kinases from cell lines and tissues. These beads enable chemoproteomics profiling of kinase inhibitors of interest in dose-dependent competition studies in combination with quantitative mass spectrometry. We present improved bead matrices that capture more than 350 protein kinases and 15 lipid kinases from human cell lysates, respectively. A multiplexing strategy is suggested that enables determination of apparent dissociation constants in a single mass spectrometry experiment. Miniaturization of the procedure enabled determining the target selectivity of the clinical BCR-ABL inhibitor dasatinib in peripheral blood mononuclear cell (PBMC) lysates from individual donors. Profiling of a set of Jak kinase inhibitors revealed kinase off-targets from nearly all kinase families underpinning the need to profile kinase inhibitors against the kinome. Potently bound off-targets of clinical inhibitors suggest polypharmacology, e.g. through MRCK alpha and beta, which bind to decernotinib with nanomolar affinity.


2021 ◽  
Vol 12 ◽  
Author(s):  
Xiao Chen ◽  
Yutong Wang ◽  
Jing Tian ◽  
Yurou Shao ◽  
Bo Zhu ◽  
...  

Resveratrol (RSV), a health-promoting natural product, has been shown to affect various cellular processes in tumor cells. However, the specific protein targets of RSV and the mechanism of action (MOA) of its anticancer effect remain elusive. In this study, the pharmacological activity of RSV was first evaluated in A549 cells, and the results showed that RSV significantly inhibited A549 cell migration but did not affect cell viability. To elucidate the underlying mechanism, a quantitative chemical proteomics approach was employed to identify the protein targets of RSV. A total of 38 target proteins were identified, and proteomic analysis showed that the targets were mainly involved in cytoskeletal remodeling and EMT, which were verified by subsequent in vitro and in vivo assays. In conclusion, RSV inhibits A549 cell migration by binding to multiple targets to regulate cytoskeletal remodeling and suppress EMT.


Sign in / Sign up

Export Citation Format

Share Document